Cas:16596-41-1 1-Pyrrolidinamine manufacturer & supplier

We serve Chemical Name:1-Pyrrolidinamine CAS:16596-41-1 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

1-Pyrrolidinamine

Chemical Name:1-Pyrrolidinamine
CAS.NO:16596-41-1
Synonyms:1-Pyrrolidinamine;N-Aminopyrrolidine;Pyrrolidine, 1-amino-;Pyrrolidin-1-amine;MFCD07368381
Molecular Formula:C4H10N2
Molecular Weight:86.136
HS Code:2933990090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:112.3±9.0 °C at 760 mmHg
Density:1.0±0.1 g/cm3
Index of Refraction:1.497
PSA:29.26000
Exact Mass:86.084396
LogP:-0.84

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like 1-Pyrrolidinamine chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,MFCD07368381 physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,Pyrrolidine, 1-amino- Use and application,Pyrrolidin-1-amine technical grade,usp/ep/jp grade.


Related News: API (Active Pharmaceutical Ingredient) means the active ingredient which is contained in medicine. 1-Pyrrolidinamine manufacturer There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association. 1-Pyrrolidinamine supplier Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion. 1-Pyrrolidinamine vendor Biogen research chief Alfred Sandrock said the FDA had painstakingly analyzed its clinical trial data over two years before reaching a conclusion. 1-Pyrrolidinamine factory There’s still hope for this approach to treating Alzheimer’s disease despite the somewhat mixed results from this trial, said Rebecca Edelmayer, senior director of scientific engagement at the Alzheimer’s Association.